Shopping Cart
- Remove All
Your shopping cart is currently empty
Q134R, a neuroprotective derivative of hydroxyquinoline, effectively inhibits nuclear factor of activated T-cell (NFAT) signaling and possesses the ability to cross the blood-brain barrier. This compound shows promise for research into Alzheimer's disease (AD) and aging-related disorders[1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $916 | 7-10 days | |
| 50 mg | $1,190 | 7-10 days | |
| 100 mg | $1,860 | 7-10 days |
| Description | Q134R, a neuroprotective derivative of hydroxyquinoline, effectively inhibits nuclear factor of activated T-cell (NFAT) signaling and possesses the ability to cross the blood-brain barrier. This compound shows promise for research into Alzheimer's disease (AD) and aging-related disorders[1]. |
| In vitro | Q134R (1-10 μM) effectively inhibits NFAT signaling without impacting calcineurin function. It achieves partial suppression of NFAT activity in primary rat astrocytes without hindering the calcineurin-mediated dephosphorylation of non-NFAT targets, both in vivo and in vitro[1]. |
| In vivo | Q134R (4 mg/kg; orally gavage; twice daily; for 7 days) treatment enhances cognitive function in rodent models of AD-like pathology[1]. |
| Synonyms | Q134R |
| Molecular Weight | 410.39 |
| Formula | C22H17F3N4O |
| Cas No. | 2022949-46-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.